Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a Bt protein Cry1A-like, a coding gene and application thereof, and can provide a new Bt virulence protein resource.
In order to achieve the purpose, the technical scheme adopted by the invention for solving the technical problems is as follows:
a Bt protein Cry1A-like has an amino acid sequence shown as SEQ ID NO.2, or has an amino acid sequence with equivalent activity, wherein one or more amino acids are substituted, deleted and/or added in the amino acid sequence shown as SEQ ID NO. 2.
The gene for coding the protein has a nucleotide sequence shown in SEQ ID No.1, or a nucleotide sequence which is obtained by substituting, deleting and/or adding one or more nucleotides and has the same activity as the nucleotide sequence shown in SEQ ID No. 1.
The invention relates to a novel Bacillus thuringiensis strain BN23-5 separated from soil in urban areas of Sichuan province, which is preserved in the common microorganism center of China Committee for culture Collection of microorganisms (CGMCC for short, address: No. 3 of West Luo 1 of Beijing area facing Yang, institute of microbiology of China academy of sciences, postal code 100101) in 7-14 days of 2014, and is classified and named as Bacillus thuringiensis (Bacillus thuringiensis), and the preservation number is CGMCC No. 9448.
The toxicity test of BN23-5 shows that BN23-5 has extremely high toxicity to lepidoptera pests and the like. A pair of specific primers is designed according to a Cry1 gene conserved sequence, genomic DNA of the primers is amplified, results show that cryI genes exist in the strain, full-length gene primers of the primers are further designed, a Cry1A-like gene is obtained by cloning, the nucleotide sequence of the Cry1A-like gene is shown in a sequence table SEQ ID No.1, the full length is 3543bp, analysis shows that the GC content is 39.20%, protein consisting of 1181 amino acids is encoded, and the amino acid composition of the Cry1A-like protein is shown in table 1.
TABLE 1 amino acid composition of Cry1A-like proteins
| Amino acids | Percent by weight% | Amino acids | Percent by weight% | Amino acids | Percent by weight% |
| Ala(A) | 6.17 | Gly(G) | 6.51 | Pro(P) | 4.37 |
| Arg(R) | 6.86 | His(H) | 2.14 | Ser(S) | 7.03 |
| Asn(N) | 6.00 | Ile(I) | 6.68 | Ter(.) | 0.09 |
| Asp(D) | 5.57 | Leu(L) | 9.43 | Thr(T | 5.66 |
| Cys(C) | 1.54 | Lys(K) | 3.00 | Trp(W) | 1.37 |
| Gln(Q) | 3.26 | Met(M) | 0.51 | Tyr(Y) | 4.88 |
| Glu(E) | 8.48 | Phe(F) | 3.86 | Val(V) | 6.60 |
The gene and the protein of the invention can be obtained by cloning or separating Bt strain BN23-5 or by a method of DNA or peptide synthesis.
The gene of the invention can be operably connected with an expression vector to obtain a recombinant expression vector capable of expressing the protein of the invention, and the expression vector can be further introduced into a host by a transgenic method such as an agrobacterium-mediated method, a gene gun method, a pollen tube channel method and the like to obtain a transformant of the transgenic Cry1A-like gene, for example, plants such as crops or fruit trees and the like, so that the transgenic plant has insect-resistant activity.
It is understood that one skilled in the art can substitute, delete and/or add one or several amino acids to obtain a mutant sequence of the protein Cry1A-like according to the amino acid sequence (SEQ ID No.2) of the protein disclosed herein, without affecting its activity. For example, in the inactive segment, Lys at position 48 is replaced by Arg or Leu at position 717 is replaced by Ile, without affecting its activity. Therefore, the Bt protein Cry1A-like also comprises a protein which is obtained by substituting, replacing and/or adding one or more amino acids in the amino acid sequence shown in SEQ ID No.2, has the same activity with the Bt protein Cry1 and is derived from Cry 1A-like.
In one embodiment of the invention, the Bt protein Cry1A-like recombinant expression vector is obtained by inserting Cry1A-like gene into expression vector pET-28a (+) to construct recombinant expression vector pET-1I.
In addition, fermentation liquor containing Cry1A-like protein can be obtained by fermenting the strain BN23-5, and the fermentation liquor is prepared into an insecticide for controlling crop pests. The skilled person can also transform the above genes into bacteria or fungi to produce the Bt protein of the invention by large-scale fermentation.
A recombinant expression vector containing the gene.
A host cell containing the recombinant expression vector.
Further, the host cell is a plant cell.
An insecticide contains the protein as active component and its pharmacologically acceptable auxiliary components.
The application of the protein in improving the insect resistance of plants.
The gene is applied to culturing transgenic plants, preparing pesticides or improving the insect resistance of plants.
The technical personnel in the field can also transform crops such as cotton, corn, rice, vegetables and the like according to the Cry1A-like gene disclosed by the invention so as to enable the crops to have corresponding insect-resistant activity. For example: by utilizing the degeneracy of codons, a Cry1A-like gene is designed into a gene sequence with rice preference codons, then the synthesized Cry1A-like gene sequence is connected with a vector pCAMBIA1300, and is transferred into a corn genome through agrobacterium mediation, so that a transgenic corn variety with insect-resistant activity is obtained.
The invention has the beneficial effects that:
the Cry1A-like protein provided by the invention is a Bt protein, has good insecticidal activity, can specifically kill pests when being used for preparing transgenic plants, and can reduce the usage amount of pesticides, reduce the cost and reduce the environmental pollution. Meanwhile, the situation that pests have resistance to the protein is not found. Therefore, the Bt protein Cry1A-like has important economic value and application prospect, and is suitable for large-scale application in improving the insect resistance of plants.
Detailed Description
The following description of the embodiments of the present invention is provided to facilitate the understanding of the present invention by those skilled in the art, but it should be understood that the present invention is not limited to the scope of the embodiments, and it will be apparent to those skilled in the art that various changes may be made without departing from the spirit and scope of the invention as defined and defined in the appended claims, and all matters produced by the invention using the inventive concept are protected.
Example 1 cloning of Cry1A-like Gene
1. A novel Bacillus thuringiensis strain BN23-5 separated from soil in the urban area of Sichuan province is preserved in the common microorganism center of China Committee for culture Collection of microorganisms (CGMCC for short, address: No. 3 of West Luo No.1 of Beijing area facing Yang, institute of microbiology of Chinese academy of sciences, postal code 100101) in 7-14 days in 2014, and is classified and named as Bacillus thuringiensis (Bacillus thuringiensis), and the preservation number is CGMCC No. 9448. The toxicity test of BN23-5 shows that BN23-5 has extremely high toxicity to lepidoptera pests and the like.
2. Then, a genome DNA purification kit (purchased from Saibance) is adopted to extract the total DNA of the strain BN23-5 as a template for amplifying the Cry1A-like gene, the designed primer sequences are shown as follows, and the amplification system is shown in Table 2:
P1:5’-ATGGAAGTGAATAATCAAAATC-3;(SEQ ID No.3)
P2:5’-CTATTCCTCCATAAGGAG-3’;(SEQ ID No.4)
TABLE 2PCR reaction System
The amplification procedure was: pre-denaturation at 94 ℃ for 5 min; denaturation at 94 ℃ for 50s, denaturation at 54 ℃ for 50s, and elongation at 72 ℃ for 2min for 30 cycles; extending for 10min at 72 ℃; the reaction was stopped at 4 ℃.
And (3) carrying out electrophoresis on the amplification reaction products on 1% agarose gel, and observing the PCR amplification result in a gel imaging system. The results are shown in FIG. 1, in which the band M is DNA marker;strip 1 is the Cry1A-like gene.
As is clear from the results of detection in FIG. 1, a sequence of about 3543bp was obtained by amplification, and the sequence was sequenced, and its nucleotide sequence was shown in SEQ ID No.1 and was identical to the target sequence.
Example 2 acquisition of Cry1A-like protein
Designing and synthesizing a pair of specific primers according to two end sequences of Cry1A-like gene open reading frames
1ITF:5'-GCCGGATCCATGGAGATAGTGAATAATCAGAAT-3';(SEQ ID No.5)
1ITR:5'-GGGGTCGACCTAAAATTCTGCCTCAAAGGTTA-3';(SEQ ID No.6)
The underlined parts of the 5' primer are BamH I and Sal I restriction sites respectively. Amplifying by taking BN23-5 total DNA as a template, connecting the enzyme digestion product with a vector pET-28a (+) subjected to double enzyme digestion, transforming E.coli DH5 alpha competent cells, extracting a plasmid of the E.coli DH5 alpha competent cells, and carrying out enzyme digestion electrophoresis, wherein the result is shown in figure 2, and astrip 1 in the figure 2 is a BamH I/Sal I double enzyme digestion product of a recombinant plasmid pET-1I; thestrip 2 is a vector pET-28 a; thestrip 3 is a recombinant plasmid pET-1I;band 4 is the inserted DNA; and the band M is DNA marker. As can be seen from the results of the electrophoresis in FIG. 2, the size of the inserted fragment matches the size of the desired target fragment.
Then transferred into recipient bacterium E.coli.BL21(DE3) (purchased from Beijing Quanjin Biotechnology Ltd.). The recombinant plasmid was designated as pET-1I, and the recombinant plasmid-containing recombinant was designated as E.coli.BL21 (2L). Culturing positive transformant in LB culture medium at 200r/min and 37 deg.C overnight, transferring the culture medium to 1L triangular flask containing 400mL LB culture medium at a ratio of 1:100, culturing at 200r/min and 37 deg.C, adding 0.6mmol/L IPTG to induce expression for 12h when OD 600 value of the culture medium reaches 0.6-0.8, centrifuging the culture medium to collect thallus, discarding supernatant, adding 30mL 10mmol/L Tris-HCl (pH 8.0), ultrasonically crushing, and detecting the expressed protein by SDS-PAGE, wherein the band M is protein marker (molecular weight from top to bottom: 120, 100, 80, 65, 50, 40, 25 KDa);
theband 1 is E.coli BL21(DE3) containing recombinant plasmid pET-1I, and the supernatant of the bacterial lysate is not induced by IPTG; theband 2 is E.coli BL21(DE3) containing recombinant plasmid pET-1I, and is precipitated from a thallus lysate after IPTG induction;lane 3 is e.coli BL21(DE3) expression protein containing vector pET-28a (negative control).
As can be seen from the detection map of FIG. 3, SDS-PAGE analysis shows that the molecular weight of Cry1A-like in the precipitate and supernatant after the ultrasonication of the thallus is about 134.3kDa, which is consistent with the predicted molecular weight of the protein.
Example 3Cry1A-like protein insecticidal Activity assay
The Cry1A-like protein obtained in example 2 is used for measuring the insecticidal activity of diamondback moth, corn borer and cotton bollworm, and the specific process is as follows.
1. And (3) raw testing of the plutella xylostella: preparing Cry1A-like protein into 6 different concentration gradients of 4, 2, 1, 0.5, 0.25, 0.01 mu g/mL and the like; selecting cabbage leaves with moderate age and tenderness, cleaning and airing; irradiating under ultraviolet lamp for 15min, and cutting into 2 × 2cm2The size of the mixture is divided into bacterial liquids with different concentrations, and the mixture is soaked for 5 min; taking out, draining off excessive liquid, air drying in sterilized culture dish, and placing 4 leaves in each culture dish with E.coli.BL21(DE3) as negative control and clear water as blank control; selecting and placing 20 healthy diamondback moths of 2-3 ages; each treatment was repeated 3 times, housed and larval mortality was investigated after 3 days.
2. Bioassay of corn borers: cry1A-like protein is prepared into 6 different concentration gradients of 200, 100, 50, 25, 12.5, 0.1 mu g/mL and the like, the protein is added into feed for raising corn borers and mixed evenly, E.coli.BL21(DE3) is used as negative control, clear water is used as blank control, 20 corn borers with 2-3 ages are added into each treatment, each treatment is repeated for 3 times, and the results are counted after 7 days.
3. The birth test of the cotton bollworm: preparing Cry1A-like protein into 6 different concentration gradients of 200, 100, 50, 25, 12.5, 0.1 μ g/mL, etc., adding protein into feed for feeding cotton bollworm, mixing, using E.coli.BL21(DE3) as negative control and clear water as blank control, and processing each position with the above-mentioned materialsAnd (4) throwing 20 cotton bollworms of 2-3 years into the cotton bollworms, repeating the treatment for 3 times, and counting the result after 3 days. Finally, LC is calculated by SPSS 10.0 software50The results are shown in Table 3.
TABLE 3 insecticidal Activity of Cry1A-like
As can be seen from the results in Table 3, the expression products have high insecticidal activity against diamond back moth, corn borer and cotton bollworm, LC500.17. mu.g/mL, 1.66. mu.g/mL and 26.31. mu.g/mL, respectively; bioassay results showed that e.coli.bl21(DE3) and blank controls had no insecticidal activity against diamondback moth, corn borer and cotton bollworm. The Cry1A-like protein developed by the invention has excellent insecticidal activity, and can be used for improving insect resistance of plants, preparation of insecticides and the like.
Sequence listing
<110> Sichuan university of agriculture
<120> Bt protein Cry1A-like and coding gene and application thereof
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 3543
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
atggagatag tgaataatca gaatcaatgc gtgccttata attgtttgaa taatcctgaa 60
atcgaaatat tagaaggcga aagaatatca gttggtaaca ccccgatcga tatttctctg 120
tcgctggtgg aacttcttat tagtgaattt gttccaggcg gtggaattat aacgggattg 180
ttgaacattg tatggggatt tgtaggtcct tcccaatggg acgcatttct tgctcaagtg 240
gaacagttaa ttaaccaaag aatagctgaa gctgtaagaa atacagcaat tcaggaatta 300
gagggaatgg cacgagttta tagaacctat gctactgctt ttgctgagtg ggaaaaagct 360
cctgatgacc cagagctaag ggaagcacta cgtacacaat ttacagcaac tgagacttat 420
ataagtggaa gaatatccgt tttaaaaatt caaaattttg aagtacagct gttatcggtg 480
tttgcccaag ctgcaaattt acatttatct ttattaagag acgttgtgtt ttttgggcaa 540
agatggggtg tttcaacgac aaccgtaaat aattactaca atgatttaac agaagagatt 600
agtacctata cagattatgc tgtacgctgg tacaatacgg gattagaacg tgtatgggga 660
ccggattcta gagactgggt aagatataat caatttagaa gagaattaac actaactgta 720
ttagatatcg tttctctatt tccgaactat gatagtagaa ggtatccaat tcgaacagtt 780
tcccaattaa caagagaaat ttatacaaac ccagtattag aaaattttga tggtagtttt 840
cgtggaatgg ctcagagaat agaacagaat attaggcaac cacatcttat ggatatcctt 900
aatacaataa ccatttatac tgatgtgcat agaggcttta attattggtc aggacatcaa 960
ataactgctt ctcctgtagg gttttcagga ccagaattta cattcccttt atttggtaat 1020
gcagggaacg cagctccacc cgtacttgtc tcattaacgg gtttggggat ttttagaaca 1080
ttatcttcac ctttttacag aagaattata ctcggttcag gtccaaataa tcaggaactg 1140
tttgtccttg atggaacgga attttctttt gcctccctaa caactaatat accttctact 1200
atatacagac aaagaggaac ggtcgattca ctagatttaa taccaccaca agataatagt 1260
gtgcccgctc gtgcgggatt tagtcatcga ttaagccatg ttacaatgct gagccaagca 1320
gccggagcag tttacacctt gagagctcca acgttttctt ggcagcatcg tagtgctgaa 1380
tttaataata taattccttc atcacaaatt acacaaatac ctttaacaaa atctactaat 1440
cttggctctg gaactactgt cgttaaagga ccaggattta caggaggaga tattctacga 1500
agaacttcac ctggccagat ttcaacctta agagtaaata ttactgcacc attatcacaa 1560
agatatcgcg taagaattcg ttatgcctct actacaaatt tacaattcca tacatcaatt 1620
gatggaagac ctattaatca ggggaatttt tcagcaacta tgagtagtgg gggtaattta 1680
cagtccggaa gctttaggac tttaggtttt actactccgt ttaacttttc aaatggatca 1740
agtgtattta cgttaagtgc tcaggtcttc aattcaggca atgaagttta tatagataga 1800
attgaatttg ttccggcaga agtaaccttt gaggcagaat ttgatttaga aagagcccaa 1860
gaggcggtga atgcgctgtt tacttctccc aatcaaatcg ggttaaaaac agatataacg 1920
gattatcata ttgatcaagt atccaatcta gttgagtgtt tatcagatga attttgtctg 1980
gatgaaaaga gagaattatc cgaaaaagtc aaacatgcga agcgactcag tgatgagcgg 2040
aatttacttc aagatccaaa ctttagaggc atcaatagac aaccagaccg tggttggaga 2100
ggaagtacgg atattaccat ccaaggtgga gatgacgtat tcaaagagaa ttacgtcaca 2160
ctaccgggca cttttgatga gtgctatcca acgtatttgt atcaaaaaat agatgaatca 2220
aaattaaaag cctacactcg ttaccgatta agagggtaca tcgaggatag tcaagactta 2280
gaaatctatt taatccgcta caatgcaaaa cacgaaaccg taaatgtacc aggtaccggg 2340
ggggtatggc cactttctgt agaaaattca attggacctt gtggcgaacc gaatcgatgc 2400
gcgccacacc ttgaatggaa tcctaatcta gagtgttcct gcagagacgg ggaaaaatgt 2460
gcacaccatt cgcatcattt ctccttggac attgatgttg gatgtacaga cttaaatgag 2520
gacttaggtg tatgggtgat attcaagatt aagacgcaag atggccatgc aagactagga 2580
aatctagagt ttctcgaaga gaaaccatta ttaggggaag cactagctcg tgtgaaaaga 2640
gcggagaaaa aatggagaga caaatgtgaa aaattggaat tggaaacaaa tattgtttat 2700
aaagaggcaa aaaaatctgt agatgcttta tttgtgaact ctcaatatga tagattacag 2760
gcggatacga atattgccat gattcatgcg gcagataaac gtgttcatag aatccgagaa 2820
gcgtatcttc cagagttatc tgtgattccg ggtgtaaatg cagacatttt cgaagaatta 2880
gaagggcgta ttttcacagc ctactctcta tatgatgcga gaaatgtcat taaaaacggt 2940
aatttcaata atggcttatc atgttggaac gtgaaagggc atgtagatgt agaagaacaa 3000
aacaaccacc gttcagtcct tgtggtccca gaatgggaag cagaagtgtc ccaagaagtt 3060
cgtgtctgtc caggacgtgg ctatatcctt cgcgttacag cgtacaaaga aggatatgga 3120
gagggctgcg taacgatcca tgagattgaa gacaatacag acgaactgaa attcagcaac 3180
tgtgtagaag aggaagtata tccaaataac acggtaacgt gtaatgatta tactgcgact 3240
caagaagaat acgggggtgt atacacttcc cgtaatcgtg gatatgacga aacttatgga 3300
agcaattctt ccgtatcagc agattatgcg tcagtctatg aagcaaaagc gtatacagat 3360
ggacgaagag agaatccttg tgaatttaac agaggatatg gggattacac accactacca 3420
gctggctatg tgacaaaaga attagagtac ttcccagaaa ccgataaggt atggattgag 3480
atcggagaaa cagaaggaac attcatcgtg gacagcgtgg aattactcct tatggaggaa 3540
tag 3543
<210> 2
<211> 1180
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 2
Met Glu Ile Val Asn Asn Gln Asn Gln Cys Val Pro Tyr Asn Cys Leu
1 5 10 15
Asn Asn Pro Glu Ile Glu Ile Leu Glu Gly Glu Arg Ile Ser Val Gly
20 25 30
Asn Thr Pro Ile Asp Ile Ser Leu Ser Leu Val Glu Leu Leu Ile Ser
35 40 45
Glu Phe Val Pro Gly Gly Gly Ile Ile Thr Gly Leu Leu Asn Ile Val
50 55 60
Trp Gly Phe Val Gly Pro Ser Gln Trp Asp Ala Phe Leu Ala Gln Val
65 70 75 80
Glu Gln Leu Ile Asn Gln Arg Ile Ala Glu Ala Val Arg Asn Thr Ala
85 90 95
Ile Gln Glu Leu Glu Gly Met Ala Arg Val Tyr Arg Thr Tyr Ala Thr
100 105 110
Ala Phe Ala Glu Trp Glu Lys Ala Pro Asp Asp Pro Glu Leu Arg Glu
115 120 125
Ala Leu Arg Thr Gln Phe Thr Ala Thr Glu Thr Tyr Ile Ser Gly Arg
130 135 140
Ile Ser Val Leu Lys Ile Gln Asn Phe Glu Val Gln Leu Leu Ser Val
145 150 155 160
Phe Ala Gln Ala Ala Asn Leu His Leu Ser Leu Leu Arg Asp Val Val
165 170 175
Phe Phe Gly Gln Arg Trp Gly Val Ser Thr Thr Thr Val Asn Asn Tyr
180 185 190
Tyr Asn Asp Leu Thr Glu Glu Ile Ser Thr Tyr Thr Asp Tyr Ala Val
195 200 205
Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg
210 215 220
Asp Trp Val Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val
225 230 235 240
Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Arg Tyr Pro
245 250 255
Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val
260 265 270
Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Met Ala Gln Arg Ile Glu
275 280 285
Gln Asn Ile Arg Gln Pro His Leu Met Asp Ile Leu Asn Thr Ile Thr
290 295 300
Ile Tyr Thr Asp Val His Arg Gly Phe Asn Tyr Trp Ser Gly His Gln
305 310 315 320
Ile Thr Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro
325 330 335
Leu Phe Gly Asn Ala Gly Asn Ala Ala Pro Pro Val Leu Val Ser Leu
340 345 350
Thr Gly Leu Gly Ile Phe Arg His Leu Ser Ser Pro Phe Tyr Arg Arg
355 360 365
Ile Ile Leu Gly Ser Gly Pro Asn Asn Gln Glu Leu Phe Val Leu Asp
370 375 380
Gly Thr Glu Phe Ser Phe Ala Ser Leu Thr Thr Asn Ile Pro Ser Thr
385 390 395 400
Ile Tyr Arg Gln Arg Gly Thr Val Asp Ser Leu Asp Leu Ile Pro Pro
405 410 415
Gln Asp Asn Ser Val Pro Ala Arg Ala Gly Phe Ser His Arg Leu Ser
420 425 430
His Val Thr Met Leu Ser Gln Ala Ala Gly Ala Val Tyr Thr Leu Arg
435 440 445
Ala Pro Thr Phe Ser Trp Gln His Arg Ser Ala Glu Phe Asn Asn Ile
450 455 460
Ile Pro Ser Ser Gln Ile Thr Gln Ile Pro Leu Thr Lys Ser Thr Asn
465 470 475 480
Leu Gly Ser Gly Ala Ala Val Val Lys Gly Pro Gly Phe Thr Gly Gly
485 490 495
Asp Ile Leu Arg Arg Thr Ser Pro Gly Gln Ile Ser Thr Leu Arg Val
500 505 510
Asn Ile Ala Ala Pro Leu Ser Gln Arg Tyr Arg Val Arg Ile Arg Tyr
515 520 525
Ala Ser Thr Thr Asn Leu Gln Phe His Thr Ser Ile Asp Gly Arg Pro
530 535 540
Ile Asn Gln Gly Asn Phe Ser Ala Thr Met Ser Ser Gly Gly Ile Leu
545 550 555 560
Gln Ser Gly Ser Phe Arg Thr Leu Gly Phe Thr Thr Pro Phe Asn Phe
565 570 575
Ser Ile Gly Ser Ser Val Phe Thr Leu Ser Ala Gln Val Phe Ile Ser
580 585 590
Gly Asn Gly Val Tyr Ile Asp Arg Ile Gly Phe Val Pro Ala Gly Val
595 600 605
Thr Phe Glu Ala Gly Phe Asp Leu Gly Arg Ala Gln Glu Ala Val Ile
610 615 620
Ala Leu Phe Thr Ser Pro Asn Gln Ile Gly Leu Lys Thr Asp Ile Thr
625 630 635 640
Asp Tyr His Ile Asp Gln Val Ser Asn Leu Val Glu Cys Leu Ser Asp
645 650 655
Glu Phe Cys Leu Asp Glu Lys Arg Glu Leu Ser Glu Lys Val Lys His
660 665 670
Ala Lys Arg Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe
675 680 685
Arg Gly Ile Asn Arg Gln Pro Asp Arg Gly Trp Arg Gly Ser Thr Asp
690 695 700
Ile Thr Ile Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr
705 710 715 720
Leu Pro Gly Thr Phe Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Lys
725 730 735
Ile Asp Glu Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Arg Leu Arg Gly
740 745 750
Tyr Ile Glu Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn
755 760 765
Ala Lys His Glu Thr Val Asn Val Pro Gly Thr Gly Gly Val Trp Pro
770 775 780
Leu Ser Val Glu Asn Ser Ile Gly Pro Cys Gly Glu Pro Asn Arg Cys
785 790 795 800
Ala Pro His Leu Glu Trp Asn Pro Asn Leu Glu Cys Ser Cys Arg Asp
805 810 815
Gly Glu Lys Cys Ala His His Ser His His Phe Ser Leu Asp Ile Asp
820 825 830
Val Gly Cys Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe
835 840 845
Lys Ile Lys Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe
850 855 860
Leu Glu Glu Lys Pro Leu Leu Gly Glu Ala Leu Ala Arg Val Lys Arg
865 870 875 880
Ala Glu Lys Lys Trp Arg Asp Lys Cys Glu Lys Leu Glu Leu Glu Thr
885 890 895
Asn Ile Val Tyr Lys Glu Ala Lys Lys Ser Val Asp Ala Leu Phe Val
900 905 910
Asn Ser Gln Tyr Asp Arg Leu Gln Ala Asp Thr Asn Ile Ala Met Ile
915 920 925
His Ala Ala Asp Lys Arg Val His Arg Ile Arg Glu Ala Tyr Leu Pro
930 935 940
Glu Leu Ser Val Ile Pro Gly Val Asn Ala Asp Ile Phe Glu Glu Leu
945 950 955 960
Glu Gly Arg Ile Phe Thr Ala Tyr Ser Leu Tyr Asp Ala Arg Asn Val
965 970 975
Ile Lys Asn Gly Asn Phe Asn Asn Gly Leu Ser Cys Trp Asn Val Lys
980 985 990
Gly His Val Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val
995 1000 1005
Val Pro Glu Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro
1010 1015 1020
Glu Arg Gly Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Glu
1025 1030 1035 1040
Glu Gly Cys Val Thr Ile His Glu Ile Glu Asp Asn Thr Asp Glu Leu
1045 1050 1055
Lys Phe Ser Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val
1060 1065 1070
Thr Cys Asn Asp Tyr Thr Ala Thr Gln Glu Glu Tyr Gly Gly Val Tyr
1075 1080 1085
Thr Ser Arg Asn Arg Gly Tyr Asp Glu Thr Tyr Gly Ser Asn Ser Ser
1090 1095 1100
Val Ser Ala Asp Tyr Ala Ser Val Tyr Glu Ala Lys Ala Tyr Thr Asp
1105 1110 1115 1120
Gly Arg Arg Glu Asn Pro Cys Glu Phe Asn Arg Gly Tyr Gly Asp Tyr
1125 1130 1135
Thr Pro Leu Pro Ala Gly Tyr Val Thr Lys Glu Leu Glu Tyr Phe Pro
1140 1145 1150
Glu Thr Asp Lys Val Trp Ile Glu Ile Gly Gly Thr Glu Gly Thr Phe
1155 1160 1165
Ile Val Asp Ser Val Glu Leu Ser Leu Met Glu Glu Ter
1170 1175 1180
<210> 3
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
atggaagtga ataatcaaaa tc 22
<210> 4
<211> 18
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
ctattcctcc ataaggag 18
<210> 5
<211> 33
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
gccggatcca tggagatagt gaataatcag aat 33
<210> 6
<211> 32
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
ggggtcgacc taaaattctg cctcaaaggt ta 32